Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03258892 · ClinicalTrials.gov registry record · NA
Sarcoma Treatment Guide in Improving Self-Monitoring in Patients With Sarcoma Receiving Chemotherapy
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT03258892 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 64 participants.
The verdict
NCT03258892, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies how well the Sarcoma Treatment Guide works in improving self-monitoring in patients with sarcoma who are receiving chemotherapy. The Sarcoma Treatment Guide may help patients with sarcoma to be better informed, become more engaged with care, encourage communication, and to better manage side effects associated with chemotherapy treatments in order to improve quality of life.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Survey Administration
- OTHER Educational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2017-05-16 |
| Est. Completion | 2020-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03258892
The ClinicalTrials.gov registry entry for NCT03258892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Quality-of-Life Assessment is the first listed.
NCT03258892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03258892 about?
NCT03258892 is a clinical study titled "Sarcoma Treatment Guide in Improving Self-Monitoring in Patients With Sarcoma Receiving Chemotherapy". This randomized pilot clinical trial studies how well the Sarcoma Treatment Guide works in improving self-monitoring in patients with sarcoma who are receiving chemotherapy. The Sarcoma Treatment Guide may help patients with sarcoma to be better informed, become more engaged with care, encourage com...
What is the current status of trial NCT03258892?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2017-05-16. Estimated completion is 2020-12-15.
What interventions are being tested in trial NCT03258892?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Survey Administration (OTHER), Educational Intervention (OTHER).
Who is sponsoring clinical trial NCT03258892?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.